diphenylhydantoin ( dfh ) treatment for epileptic patients has shown adverse effects such as malignant lymphadenopathy , systemic lupus erithematosus , periarteritis nodosa and recently immunological alterations such as a decreased lymphocytic response to fitohemaglutinin and serum iga concentration , therefore we thought dfh effect on secretory iga would be an important finding .
C0031507
diphenylhydantoin
C0014544
epileptic